2020
DOI: 10.1007/978-1-0716-0896-8_3
|View full text |Cite
|
Sign up to set email alerts
|

Measurement of Superoxide Production in Acute Hypoxia by Fixed-Cell Microscopy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…In this situation, the production of ROS is low, but measurable and is commonly assigned to CI, the outer ubiquinone-binding site of CIII (CIII o ) and OGDH [22][23][24] in the so-called forward electron transfer (FET) ( Figure 2A). This mode of ROS production can be exacerbated by ubiquinone-binding site inhibitors of CI, such as rotenone or piericidin A [25][26][27][28], or by inhibitors of the inner ubiquinone-binding site of CIII (CIII i ), such as antimicyn A [29,30]. On the other hand, to decrease this type of ROS production, especially after the application of the mentioned compounds, inhibitors of the flavin site of CI, such as diphenyleneiodonium (DPI; [31,32]), CIII o blockers, such as myxothiazol, stigmatellin, or mucidin [33], and OGDH inhibitors, such as succinyl phosphonate or 3-methyl-2-oxopentanoate [24,34], can be applied.…”
Section: Modes Of Ros Production By Mitochondriamentioning
confidence: 99%
“…In this situation, the production of ROS is low, but measurable and is commonly assigned to CI, the outer ubiquinone-binding site of CIII (CIII o ) and OGDH [22][23][24] in the so-called forward electron transfer (FET) ( Figure 2A). This mode of ROS production can be exacerbated by ubiquinone-binding site inhibitors of CI, such as rotenone or piericidin A [25][26][27][28], or by inhibitors of the inner ubiquinone-binding site of CIII (CIII i ), such as antimicyn A [29,30]. On the other hand, to decrease this type of ROS production, especially after the application of the mentioned compounds, inhibitors of the flavin site of CI, such as diphenyleneiodonium (DPI; [31,32]), CIII o blockers, such as myxothiazol, stigmatellin, or mucidin [33], and OGDH inhibitors, such as succinyl phosphonate or 3-methyl-2-oxopentanoate [24,34], can be applied.…”
Section: Modes Of Ros Production By Mitochondriamentioning
confidence: 99%